Search for: "AMGEN INC." Results 261 - 280 of 704
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2020, 7:54 am by Dennis Crouch
The Federal Circuit today denied two en banc rehearing petitions: Amgen Inc. v. [read post]
8 May 2021, 10:26 pm by Patent Docs
The panel will cover recent developments in the Hatch-Waxman and BPCIA litigation and legislation, in particular, the Federal Circuit decisions in Amgen Inc. v. [read post]
14 Apr 2013, 8:41 pm by Patent Docs
Joshua Sarnoff of the DePaul University College of Law; and Stuart Watt of Amgen Inc. will discuss the Justices' questioning during oral argument in AMP v. [read post]
6 Nov 2021, 9:15 pm by Patent Docs
In the second installment of a three part series, Emily Johnson of Amgen, Inc., Jay Tatachar of Ericsson, Vaishali Udupa of Hewlett Packard Enterprise, Todd Walters of Buchanan Ingersoll & Rooney PC, and Jenifer Ward General Electric Co. will discuss the pros and cons of the various options for challenging the validity of patent claims, giving perspectives from both challenger and patent owner, and highlight... [read post]
28 Feb 2018, 9:35 pm by Patent Docs
The memorandum, entitled "Clarification of Written Description Guidance For Claims Drawn to Antibodies and Status of 2008 Training Materials," is divided into three sections, which address the Federal Circuit's recent decision in Amgen Inc. v. [read post]
13 Jan 2012, 8:59 pm by Patent Docs
A panel consisting of Ned Israelsen of Knobble Martens Olson & Bear, LLP; Stuart Watt of Amgen Inc.; and Harold Wegner of Foley & Lardner, LLP will: • Give recommendations on how companies can restructure their invention disclosure and priority filing systems, including consideration of trade secret protection; • Consider how the new U.S. first-to-file system will be different than those that now exist internationally, and how those differences should be dealt… [read post]
7 Jul 2020, 9:15 am by Rebecca Tapscott
District Court for the District of New Jersey in Immunex Corporation, Amgen Manufacturing, Limited, Hoffman-La Roche Inc. v. [read post]
17 May 2017, 4:10 am by Edith Roberts
Amgen Inc., and Henson v. [read post]
18 Nov 2011, 6:58 am
Amgen et al., it was also the basis for a securities lawsuit alleging that a retirement investor was misled by public statements made by Amgen Inc. and four of its officers about the anemia drugs Aranesp and Epogen. [read post]
29 Mar 2013, 5:00 am by Kimberly A. Kralowec
Supreme Court addresed Rule 23(b)(3) class certification for the first time since Amgen Inc. v. [read post]
28 Apr 2015, 9:14 am by Dennis Crouch
(“Amgen”) crowd, or move to the left and side with the folks from Sandoz Inc. [read post]
9 Jul 2012, 3:00 pm by fraudfighters
The whistleblower in this case, Ivey Woodard, is a former employee of Amgen: the maker of Epogen. [read post]